Abiopharma

🔍 Hill Stephen J. (Executive)

Company: Lyell Immunopharma, Inc. (LYEL)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Sold 89 shares of Common Stock at $14.34 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 17,805.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.
• F2: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $14.27 to $14.34 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.